Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.7980
-0.0071 (-0.88%)
At close: Mar 6, 2026, 4:00 PM EST
0.7821
-0.0159 (-1.99%)
After-hours: Mar 6, 2026, 6:03 PM EST

Cytosorbents Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
7.543.2814.1322.1452.1471.42
Cash & Short-Term Investments
7.543.2814.1322.1452.1471.42
Cash Growth
32.55%-76.79%-36.19%-57.53%-27.00%483.87%
Accounts Receivable
7.437.326.065.664.525.16
Inventory
42.733.383.464.772.67
Other Current Assets
2.358.271.832.492.873.2
Total Current Assets
21.3121.625.433.7664.382.45
Net Property, Plant & Equipment
19.2720.5122.1223.3518.573.15
Other Long-Term Assets
5.175.265.446.126.654.35
Total Assets
45.7547.3752.9663.2389.5289.95
Accounts Payable
3.043.343.81.662.811.84
Accrued Expenses
6.566.037.367.9510.317.87
Current Portion of Long-Term Debt
--2.5---
Current Portion of Leases
0.520.450.370.110.570.45
Total Current Liabilities
10.119.8314.049.7113.6910.15
Long-Term Debt
14.57142.545--
Long-Term Leases
12.0512.4412.913.1413.250.58
Total Long-Term Liabilities
26.6226.4415.4418.1413.250.58
Total Liabilities
36.7336.2729.4827.8626.9410.73
Common Stock
0.060.060.050.040.040.04
Additional Paid-in Capital
319.51310.81306.19287283.19277.53
Accumulated Other Comprehensive Income
-3.844.250.532.330.53-1.73
Retained Earnings
-306.71-304.01-283.29-254-221.19-196.63
Shareholders' Equity
9.0211.1123.4835.3762.5879.22
Total Liabilities & Equity
45.7547.3752.9663.2389.5289.95
Total Debt
27.1426.8918.3118.2513.821.03
Net Cash (Debt)
-19.6-23.61-4.183.8938.3270.39
Net Cash Growth
----89.84%-45.57%-
Net Cash Per Share
-0.32-0.43-0.09-0.001.81
Book Value
9.0211.1123.4835.3762.5879.22
Book Value Per Share
0.150.200.530.000.002.04
Tangible Book Value
9.0211.1123.4835.3762.5879.22
Tangible Book Value Per Share
0.150.200.530.000.002.04
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q